Botulinum toxin type A in the management of masseter muscle hypertrophy.

doi:10.1016/J.JOMS.2004.04.025

Paper

Botulinum toxin type A in the management of masseter muscle hypertrophy.

Published 2005 · W. Castro, R. Gomez, Jacqueline Da Silva Oliveira

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons

Q1 SJR score

56

Citations

1

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Botulinum toxin type A is a successful and safe treatment for masseter muscle hypertrophy, reducing pain and improving function in patients.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Botulinum toxin type A in the management of masseter muscle hypertrophy.

References

Citations